CellCarta

ProteoGenex is an established, innovative provider of biological specimens and clinical information of the highest quality standards.

We are a privately held US company founded in Los Angeles, CA in 2003. With headquarters in Culver City, CA, we also have a large, state-of-the-art research laboratory in Moscow, Russia.

The ProteoGenex team consists of 35 employees, including 30 Molecular Biologists, Cell Biologists, Biochemists, and Pathologists (15 PhDs, 5 MDs, 15 MSs).

Our biorepository offers an extensive inventory of biospecimens as well as an exclusive, custom-design human tissue-based research service, which is the company’s largest and fastest growing business segment.
Our unique and comprehensive biobank is composed of well-defined and categorized clinical samples, including frozen and FFPE tissues, blood, serum, plasma, bone marrow, tissue microarrays, etc. All ProteoGenex specimens are collected from a vast network of academic and professional clinical institutions under strict regulatory and ethical standards.

We have over 200,000 individual biomaterials covering disease targets in the fields of Oncology, Dermatology, Neurology, Immunology, Infectious Diseases, Autoimmune and Metabolic Disorders, and many more. Our products are derived from a variety of diseased human sources as well as from normal tissues. All specimens are supported by extensive pathology information and patient’s’ clinical history documentation.

Westat offers innovative professional services to help clients improve outcomes in health, education, social policy, and transportation. We are dedicated to improving lives through research.

Expertise

• Data Collection & Management
• Clinical Trials
• Statistical Research & Survey Methods
• Evaluation
• Communications & Social Marketing

Staff and Locations

Westat’s staff of more than 2,000 are located at our headquarters in Rockville, Maryland, near Washington, DC. Additional staff are located at Westat’s data collection survey processing facilities, at our Telephone Research Center facilities, and throughout our nationwide field operations.

Westat also maintains research offices near our clients in Atlanta, Georgia; Cambridge, Massachusetts; Raleigh/Durham, North Carolina; Philadelphia, Pennsylvania; Houston, Texas; and San Antonio, Texas. We have international offices in Liberia, Costa Rica; Johannesburg, South Africa; and Bangkok, Thailand.

Westat is committed to providing accessible media on LinkedIn. Should you experience difficulties with any posted media, please send us a message at Section508Coordinator@westat.com. An alternative format will be provided upon request.

MBL International Corporation (MBLI) is a leading life science company focused on providing solutions for researchers in the life sciences, drug discovery and development and clinical diagnostics fields. Our special emphasis is on immunology, immuno-oncology, oncology and autoimmune disease areas. As a JSR Life Sciences Company, MBLI is committed to improve the probability of success, decrease timelines, and increase the efficacy of biologics-based therapies for the benefit of patients.

Our products are used widely in academic research and medical institutions, pharmaceutical and biotechnology companies, government agencies as well as hospital and reference laboratories. We are focused on developing high quality products and have high standards for quality control in our manufacturing process. Our products include MHC monomers and multimers, antibodies, recombinant proteins, fluorescent proteins, and ELISA kits. Our products are highly cited and support numerous research fields relating to oncology, allergy, apoptosis, autophagy, epigenetics and neuroscience.

MBLI is known for its line of immune monitoring reagents, including MHC Tetramers and Monomers, as well as our line of QuickSwitch™ products for screening peptides and neoantigens. We help researchers to acquire reliable and reproducible immune monitoring results for the areas of immuno-oncology, autoimmune, vaccine development and more.

MBLI is committed to increasing the efficiency and effectiveness of its customers’ science by delivering quality products with uncompromising support through our scientific sales, customer service, and technical support teams. Our goal is to ensure that our customers get the products and assistance when they need it.

Headquartered in Woburn, MA, with a manufacturing location in Des Plaines, IL, MBLI’s extens

Contact MBL International today to learn more about how we can help you discover ways to make your science more efficient and effective. Contact sales@mblintl.com

Cellworks is a world leader in Precision Medicine. We help physicians and payers navigate to the most efficacious, cost-effective treatments for patients in a transparent and timely manner. Cellworks’ key therapeutic areas are Oncology, Immunology, Dermatology and Infectious Diseases. Cellworks’ unique bio-simulation platform is a unified representation of biological knowledge, curated from heterogeneous datasets, applied to finding cure. Since 2005, backed by Artiman Ventures and Sequoia Capital, Cellworks has the world’s strongest trans-disciplinary team of molecular biologists, cellular pathway modelers, and internet software technologists working towards a common goal – attacking serious diseases to improve the lives of patients.

CTI Clinical Trial and Consulting Services is a global, privately held, full-service contract research organization (CRO), delivering a complete spectrum of clinical trial and consulting services throughout the lifecycle of development, from concept to commercialization. CTI’s focused therapeutic approach provides pharmaceutical, biotechnology, and medical device firms with clinical and disease area expertise in rare diseases, regenerative medicine/gene therapy, immunology, transplantation, nephrology, hematology/oncology, neurology, infectious diseases, hepatology, cardiopulmonary, and pediatric populations. CTI also offers a fully integrated multi-specialty clinical research site that conducts phase I-IV trials. CTI has a passion for helping life-changing therapies succeed in chronically and critically ill patient populations. With clinical trial experience across 6 continents, CTI partners with research sites, patients, and sponsors to fulfill unmet medical needs. CTI is headquartered in Cincinnati, OH, with operations across North America, Europe, Latin America, and Asia-Pacific. For more information visit www.ctifacts.com